Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NANP | Q8TBE9 | 2/20 | 0.52 |
| ▸ | CD22 | P20273 | 14/20 | 0.50 |
| ▸ | MAG | P20916 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL442944 | 0.91 | NANP (0.61) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL15321632 | 0.89 | NANP (0.61) | NANPCD22MAG | |
| SCHEMBL8459208 | 0.89 | NANP (0.43) | NANPCD22MAG | |
| SCHEMBL27587619 | 0.88 | NANP (0.49) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL27881986 | 0.87 | CD22 (0.51) | NANPCD22MAG | |
| SCHEMBL284328 | 0.86 | NANP (0.52) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL3746151 | 0.85 | NANP (0.61) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL8664558 | 0.85 | NANP (0.64) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL16416308 | 0.83 | NANP (0.59) | NANPCD22MAGL3MBTL1 | |
| SCHEMBL2190269 | 0.83 | NANP (0.59) | NANPCD22MAGL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023057386-A1 | COMPOSITIONS FOR PREVENTING AND/OR TREATING DEMYELINATION | MJN U.S. HOLDINGS LLC (US) | 2023-04-13 | — | — | WO | claimed |
| EP-4003365-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | Lifescience AS (NO) | 2022-06-01 | — | — | EP | claimed |
| CN-114450026-A | Sialic acid for use in the treatment of psoriasis | 生命科学股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| WO-2021019295-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | REMMEREIT JAN (NO) | 2021-02-04 | — | — | WO | claimed |
| WO-2023111689-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING INFECTIONS IN FISH | LIFESCIENCE AS (NO) | 2023-06-22 | — | — | WO | disclosed |
| WO-2023057386-A1 | COMPOSITIONS FOR PREVENTING AND/OR TREATING DEMYELINATION | MJN U.S. HOLDINGS LLC (US) | 2023-04-13 | — | — | WO | disclosed |
| EP-4125926-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING CORONAVIRUS INFECTION | Lifescience AS (NO) | 2023-02-08 | — | — | EP | disclosed |
| EP-4003365-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | Lifescience AS (NO) | 2022-06-01 | — | — | EP | disclosed |
| CN-114450026-A | Sialic acid for use in the treatment of psoriasis | 生命科学股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
| WO-2021198774-A1 | SIALIC ACID COMPOSITIONS FOR USE IN INHIBITING AND TREATING CORONAVIRUS INFECTION | LIFESCIENCE AS (NO) | 2021-10-07 | — | — | WO | disclosed |
| WO-2021019295-A1 | SIALIC ACID FOR USE IN THE TREATMENT OF PSORIASIS | REMMEREIT JAN (NO) | 2021-02-04 | — | — | WO | disclosed |
| EP-2704597-A1 | PERFORMANCE ENHANCING COMPOSITIONS AND METHODS OF USE | Life Science Nutrition AS (NO) | 2014-03-12 | — | — | EP | disclosed |
| WO-2012150504-A1 | PERFORMANCE ENHANCING COMPOSITIONS AND METHODS OF USE | LIFE SCIENCE NUTRITION AS (NO) | 2012-11-08 | — | — | WO | disclosed |
| EP-0293940-A1 | Monoclonal antibody and method for preparation of hybridoma producing said antibody | KONICA CORPORATION (JP) | 1988-12-07 | — | — | EP | disclosed |